As NfL levels thus reflect disease severity and disease progression rates, but not clinical disease duration (Fig EV1), they seem to capture the functional stage and ongoing neuronal decay of SCA3 disease, rather than the mere calendrical estimate of duration of the disease. The gene discussed is NEFL; the disease is Spinocerebellar ataxia type 3.